Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu
Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
| Name | triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane |
| Synonyms | 2-(triphenyl-phosphanylidene)-propionic acid ethyl ester |
| CAS Number | 21382-82-1 |
| CAT Number | RF-PI179 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C23H23O2P |
| Molecular Weight | 362.41 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | Yellow Powder |
| Purity / Analysis Method | ≥98.0% (HPLC) |
| Loss on Drying | ≤1.0% (60℃, 2h) |
| Sum of PH3P+PH3PO | ≤2.0% (HPLC) |
| Unspecified Related Substance | ≤0.5% (HPLC) |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Sofosbuvir (CAS: 1190307-88-0) |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Sofosbuvir is a drug used for the treatment of hepatitis C. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Oral sofosbuvir was generally well tolerated in patients with chronic hepatitis C. The most commonly reported adverse events and laboratory abnormalities in patients receiving sofosbuvir plus ribavirin with or without peginterferon-alpha were consistent with those expected in patients receiving treatment with ribavirin and peginterferon-alpha, and co-administering sofosbuvir did not appear to increase the frequency or severity of these adverse events or laboratory abnormalities.
Product detail pictures:
Related Product Guide:
We have now probably the most innovative production equipment, experienced and qualified engineers and workers, regarded high quality control systems and also a friendly expert income team pre/after-sales support for Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu , The product will supply to all over the world, such as: Slovakia, Thailand, Sydney, Corporate goal: Customers' satisfaction is our goal, and sincerely hope to establish long-terms stable cooperative relations with customers to jointly develop the market. Building brilliant tomorrow together!Our company regards "reasonable prices, efficient production time and good after-sales service" as our tenet. We hope to cooperate with more customers for mutual development and benefits. We welcome potential buyers to contact us.
By Julia from Istanbul - 2017.06.25 12:48
Managers are visionary, they have the idea of "mutual benefits, continuous improvement and innovation", we have a pleasant conversation and Cooperation.
By Melissa from Pakistan - 2018.06.26 19:27